Clinical Trial Update: Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients

View source ↗

Summary

A pharmacokinetic study evaluated nadroparin dosing and associated serum HGF levels in gynecologic female patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Nadroparin (nadroparin sodium)

Snippet

Sponsor: Azienda Ospedaliera San Giovanni Battista | Conditions: Genital Diseases, Female, Ovarian Neoplasms | Status: COMPLETED